biotech · Type 1 Diabetes · Coronavirus · SABS
SAB Biotherapeutics
SAB Biotherapeutics is a biotech organization headquartered in Gaithersburg, USA. It trades on NYSE under ticker SABS. Primary therapeutic focus areas include Type 1 Diabetes, Coronavirus, Influenza A H1N1, Influenza Typ
Gaithersburg, USA HQ
2016 Founded
39 Employees
Public company Type
SABS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Gaithersburg, USA
- Founded
- 2016
- Employees
- 39
- Programs
- 8
- Drugs
- 10
- Patents
- 1
High Dose SAB-142
Phase 2 · small molecule · Type 1 Diabetes
High Dose SAB-142 for Type 1 Diabetes is a Phase 2 program (small_molecule) at SAB Biotherapeutics with 1 ClinicalTrials.gov record(s).
Internal code SAB-142-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- SAB Biotherapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Type 1 Diabetes
- Status
- active
- Trials
- 1